Titlebook: Incentives for Research, Development, and Innovation in Pharmaceuticals; Walter García-Fontes Textbook 2011 Springer Healthcare Iberica, S

Rebate

违反

MOCK

When patents are not enough: Supplementary incentives for pharmaceutical innovation,force exclusive rights to the patented invention for a fixed period of time. The particular strength of the system is that patents offer a reward correlated with the value that consumers obtain from the product. Firms make decisions to invest in innovation based on their own information about the pr

BULLY

打包

The use of pay-for-performance for drugs: Can it improve incentives for innovation?,rely “paying for pills”. Hard-pressed health care payers want to know that they are getting what they are paying for — health and other benefits for patients. Pharmaceutical companies are not prepared to accept prices that they think do not reflect the innovative value that their expensive R&D inves

Oversee

innate

Obedient

领先

MIRE